Knott David M Jr »

Mersana Therapeutics shares owned by Knott David M Jr

Quarter-by-quarter ownership of Mersana Therapeutics (MRSN) shares owned by Knott David M Jr from 13F filings

Historical chart of Knott David M Jr investment in Mersana Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mersana Therapeutics held by Knott David M Jr consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mersana Therapeutics by Knott David M Jr

Quarter filed Position value Share count Share price at filing
2025-12-31 $3.2M 112k 28.93

More positions owned by Knott David M Jr

Calumet Common (CLMT)
Apollo Global Management Common (APO)
Alphabet Inc-Cl C Common (GOOG)
Syndax Pharmaceutical Common (SNDX)
Xeris Biopharma Holdings Common (XERS)
Travere Therapeutics Common (TVTX)
Bridgebio Pharma Common (BBIO)
Protagonist Therapeutics Common (PTGX)
JPMorgan Chase & Co. Common (JPM)
Janus Henderson AAA CLO ETF Common (JAAA)
Viridian Therapeutics Common (VRDN)
Catalyst Pharmaceuticals Common (CPRX)
Cogent Biosciences Common (COGT)
Mersana Therapeutics Common (MRSN)
Arcus Biosciences Common (RCUS)

View all positions for Knott David M Jr

Top funds holding Mersana Therapeutics

Nextech Invest
Alamea Verwaltungs GmbH
Bain Capital Life Sciences Investors
Vanguard Group
Rock Springs Capital Management
Knott David M Jr
Acadian Asset Management
Affinity Asset Advisors
BlackRock
Millennium Management
Gabelli Funds
AQR Capital Management
Geode Capital Management
Two Sigma Advisers
Mackenzie Financial

View all funds holding Mersana Therapeutics